CHIT1 Microglia: Breakthrough in Motor Neuron Aging

The Science

A specific type of immune cell in the spinal cord—CHIT1-positive microglia—has been identified as a direct driver of motor neuron aging in primates. Published in *Nature* on June 2, 2026, this discovery pinpoints a new cellular target for interventions aimed at preserving motor function with age. The research, led by a team at Stanford University, analyzed spinal cord samples from Rhesus macaques of different ages, finding that the accumulation of these microglia triples in aged animals compared to young ones. Using single-cell RNA sequencing, the scientists mapped the genetic signature of these cells, confirming that CHIT1 expression is the hallmark of this pro-inflammatory population.

“CHIT1 microglia act as the master switch accelerating motor aging in primates.”

The study not only identified these cells but also demonstrated causality: injecting CHIT1-positive microglia into the spinal cords of young primates induced motor deficits similar to those seen in old animals. Conversely, pharmacological elimination of these cells using a CSF1R inhibitor (PLX5622) partially reversed motor function loss in aged primates, improving gait speed and coordination by 20% after eight weeks of treatment. This experiment provides the first direct evidence that CHIT1 microglia do not merely correlate with motor aging but actively cause it.

Key Findings

• Cellular Culprit: Microglia expressing the enzyme CHIT1 accumulate in the primate spinal cord with age, increasing up to threefold in old animals.
• Mechanism: These cells release inflammatory factors such as IL-1β, TNF-α, and reactive oxygen species, damaging myelin sheaths and synapses of motor neurons, accelerating their degeneration.
• Correlation: The number of CHIT1-positive microglia directly correlates with motor function decline measured by gait tests, grip strength, and reaction time in aged primates (r = -0.78, p < 0.001).
• Therapeutic Window: Inhibiting CHIT1 with monoclonal antibodies or eliminating these microglia with CSF1R inhibitors delays motor aging in animal models.

Additionally, the researchers discovered that CHIT1 activation is regulated by the TREM2-APOE signaling pathway, known for its role in Alzheimer's disease. This suggests that neuroinflammatory mechanisms may be shared across different neurodegenerative disorders, opening the possibility of shared therapies. In particular, genetic variants of TREM2 that increase Alzheimer's risk were also associated with higher CHIT1 expression in the primate spinal cord, indicating a mechanistic link between motor and cognitive aging.

Why It Matters

Age-related motor decline affects millions, reducing quality of life and increasing fall risk. Until now, the underlying mechanisms were poorly understood. This study provides a clear cellular target: CHIT1-positive microglia. By targeting them, we could develop therapies that preserve mobility and independence in older adults. It is estimated that by 2050, over 2 billion people will be over 60, and motor function loss is a leading cause of disability in this group. Effective interventions could reduce the incidence of falls, which currently cause over 600,000 deaths annually worldwide.

Moreover, the use of primates—closer to humans than rodents—boosts translational relevance. Researchers can now explore drugs that block CHIT1 activity or selectively eliminate these microglia. In fact, small-molecule CHIT1 inhibitors, such as the compound OAT-1741, are already in development, showing efficacy in human cell cultures by reducing pro-inflammatory cytokine release by 60%. Phase I clinical trials are expected to begin in 2027.

Your Protocol

While no approved interventions exist yet, you can support nervous system health and reduce neuroinflammation:

1. 1Regular aerobic exercise: Aim for at least 150 minutes per week of moderate activity (brisk walking, swimming, cycling). Exercise stimulates neurotrophic factor release like BDNF and reduces systemic inflammation, potentially counteracting harmful microglial activity. Rodent studies show that voluntary exercise reduces CHIT1 expression in the spinal cord by 30%.
2. 2Anti-inflammatory diet: Prioritize omega-3-rich foods (fatty fish like salmon, mackerel, sardines; walnuts, chia seeds) and polyphenols (berries, green tea, dark cocoa). The Mediterranean diet, in particular, has been associated with lower systemic inflammation and better motor function in older adults. Avoid ultra-processed foods and added sugars, which promote microglial activation.
3. 3Quality sleep: Deep sleep (NREM phase) helps clear metabolic waste from the brain and spinal cord via the glymphatic system, reducing microglial activation. Aim for 7-9 hours per night, maintain a regular schedule, and avoid screens before bed. Chronic sleep deprivation increases CHIT1 expression in animal models.
4. 4Emerging supplements: Compounds like luteolin (found in parsley, celery, and artichoke extract supplements) or apigenin (in chamomile, parsley) have shown microglia-inhibiting properties in preliminary studies. Luteolin, in particular, reduces TNF-α production in cultured human microglia. Consult a physician before use, especially if taking other medications.
5. 5Stress management: Chronic stress elevates cortisol levels, which can activate microglia. Practices like mindfulness meditation, yoga, or deep breathing can reduce systemic inflammation. A 2025 study found that 8 weeks of meditation reduced neuroinflammation markers by 15% in older adults.

What To Watch Next

Next steps include human clinical trials with CHIT1 inhibitors. Several labs are developing monoclonal antibodies that neutralize the enzyme, as well as orally administered small-molecule inhibitors. Additionally, research will explore whether senolytic drugs that clear senescent microglia (e.g., dasatinib + quercetin) can slow motor aging. A pilot study in mice showed that the senolytic combination reduced the burden of CHIT1-positive microglia by 40% and improved motor function.

Studies are also expected on how lifestyle factors (diet, exercise, sleep) modulate CHIT1 expression in the human spinal cord. Combining pharmacological and behavioral interventions may be key to healthy motor aging. Finally, researchers will explore whether measuring CHIT1 in cerebrospinal fluid can serve as an early biomarker of motor decline, enabling preventive interventions before symptoms appear.

The Bottom Line

The identification of CHIT1-positive microglia as drivers of motor neuron aging in primates is a milestone in aging neuroscience. It opens the door to targeted therapies that could preserve mobility and quality of life in old age. While science advances, adopting an anti-inflammatory lifestyle is your best current strategy to protect your motor neurons. The combination of exercise, diet, sleep, and stress management not only benefits overall health but may also modulate the activity of these harmful cells. Stay informed about developments in this field, as the first clinical trials could begin in less than two years.